Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1996 Apr 1;183(4):1515–1525. doi: 10.1084/jem.183.4.1515

Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids

PMCID: PMC2192519  PMID: 8666909

Abstract

Lipid bodies, lipid rich cytoplasmic inclusions, are characteristically abundant in vivo in leukocytes associated with inflammation. Because lipid bodies are potential reservoirs of esterified arachidonate and sites at which eicosanoid-forming enzymes may localize, we evaluated mechanisms of lipid body formation in neutrophils (PMN). Among receptor- mediated agonists, platelet activating factor (PAF), but not C5a, formyl-methyl-phenylalanine, interleukin 8, or leukotriene (LT) B4, induced the rapid formation of lipid bodies in PMN. This action of PAF was receptor mediated, as it was dose dependently inhibited by the PAF receptor antagonist WEB 2086 and blocked by pertussis toxin. Lipid body induction by PAF required 5-lipoxygenase (LO) activity and was inhibited by the 5-lipoxygenase-activating protein antagonist MK 886 and the 5-LO inhibitor zileuton, but not by cyclooxygenase inhibitors. Corroborating the dependency of PAF-induced lipid body formation on 5- LO, PMN and macrophages from wild-type mice, but not from 5-LO genetically deficient mice, formed lipid bodies on exposure to PAF both in vitro and in vivo within the pleural cavity. The 5-LO product inducing lipid body formation was not LTB4 but was 5(S)- hydroxyeicosatetraenoic acid [5(S)-HETE], which was active at 10-fold lower concentrations than PAF and was also inhibited by pertussis toxin but not by zileuton or WEB 2086. Furthermore, 5-HETE was equally effective in inducing lipid body formation in both wild-type and 5-LO genetically deficient mice. Both PAF- and 5(S)-HETE-induced lipid body formation were inhibited by protein kinase C (PKC) inhibitors staurosporine and chelerythrine, the phospholipase C (PLC) inhibitors D609 and U-73122, and by actinomycin D and cycloheximide. Prior stimulation of human PMN with PAF to form lipid bodies enhanced eicosanoid production in response to submaximal stimulation with the calcium ionophore A23187; and the levels of both prostaglandin (PG) E2 and LTB4 correlated with the number of lipid bodies. Furthermore, pretreatment of cells with actinomycin D or cycloheximide inhibited not only the induction of lipid body formation by PAF, but also the PAF- induced "priming" for enhanced PGE2 and LTB4 in PMN. Thus, the compartmentalization of lipids to form lipid bodies in PMN is dependent on specific cellular responses that can be PAF receptor mediated, involves signaling through 5-LO to form 5-HETE and then through PKC and PLC, and requires new protein synthesis. Since increases in lipid body numbers correlated with priming for enhanced PGE2 and LTB4 production in PMN, the induction of lipid bodies may have a role in the formation of eicosanoid mediators by leukocytes involved in inflammation.

Full Text

The Full Text of this article is available as a PDF (1.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauldry S. A., Wykle R. L., Bass D. A. Differential actions of diacyl- and alkylacylglycerols in priming phospholipase A2, 5-lipoxygenase and acetyltransferase activation in human neutrophils. Biochim Biophys Acta. 1991 Jul 9;1084(2):178–184. doi: 10.1016/0005-2760(91)90218-7. [DOI] [PubMed] [Google Scholar]
  2. Braquet P., Touqui L., Shen T. Y., Vargaftig B. B. Perspectives in platelet-activating factor research. Pharmacol Rev. 1987 Jun;39(2):97–145. [PubMed] [Google Scholar]
  3. Carter G. W., Young P. R., Albert D. H., Bouska J., Dyer R., Bell R. L., Summers J. B., Brooks D. W. 5-lipoxygenase inhibitory activity of zileuton. J Pharmacol Exp Ther. 1991 Mar;256(3):929–937. [PubMed] [Google Scholar]
  4. Chen X. S., Sheller J. R., Johnson E. N., Funk C. D. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature. 1994 Nov 10;372(6502):179–182. doi: 10.1038/372179a0. [DOI] [PubMed] [Google Scholar]
  5. Clapham D. E. Calcium signaling. Cell. 1995 Jan 27;80(2):259–268. doi: 10.1016/0092-8674(95)90408-5. [DOI] [PubMed] [Google Scholar]
  6. Cockcroft S. G-protein-regulated phospholipases C, D and A2-mediated signalling in neutrophils. Biochim Biophys Acta. 1992 Aug 14;1113(2):135–160. [PubMed] [Google Scholar]
  7. Coimbra A., Lopes-Vaz A. The presence of lipid droplets and the absence of stable sudanophilia in osmium-fixed human leukocytes. J Histochem Cytochem. 1971 Sep;19(9):551–557. doi: 10.1177/19.9.551. [DOI] [PubMed] [Google Scholar]
  8. Dvorak A. M., Morgan E., Schleimer R. P., Ryeom S. W., Lichtenstein L. M., Weller P. F. Ultrastructural immunogold localization of prostaglandin endoperoxide synthase (cyclooxygenase) to non-membrane-bound cytoplasmic lipid bodies in human lung mast cells, alveolar macrophages, type II pneumocytes, and neutrophils. J Histochem Cytochem. 1992 Jun;40(6):759–769. doi: 10.1177/40.6.1316915. [DOI] [PubMed] [Google Scholar]
  9. Dvoràk A. M., Morgan E. S., Tzizik D. M., Weller P. F. Prostaglandin endoperoxide synthase (cyclooxygenase): ultrastructural localization to nonmembrane-bound cytoplasmic lipid bodies in human eosinophils and 3T3 fibroblasts. Int Arch Allergy Immunol. 1994 Nov;105(3):245–250. doi: 10.1159/000236764. [DOI] [PubMed] [Google Scholar]
  10. Glaser K. B., Asmis R., Dennis E. A. Bacterial lipopolysaccharide priming of P388D1 macrophage-like cells for enhanced arachidonic acid metabolism. Platelet-activating factor receptor activation and regulation of phospholipase A2. J Biol Chem. 1990 May 25;265(15):8658–8664. [PubMed] [Google Scholar]
  11. Goulet J. L., Snouwaert J. N., Latour A. M., Coffman T. M., Koller B. H. Altered inflammatory responses in leukotriene-deficient mice. Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12852–12856. doi: 10.1073/pnas.91.26.12852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Griffiths R. J., Pettipher E. R., Koch K., Farrell C. A., Breslow R., Conklyn M. J., Smith M. A., Hackman B. C., Wimberly D. J., Milici A. J. Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis. Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):517–521. doi: 10.1073/pnas.92.2.517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Henderson W. R., Jr The role of leukotrienes in inflammation. Ann Intern Med. 1994 Nov 1;121(9):684–697. doi: 10.7326/0003-4819-121-9-199411010-00010. [DOI] [PubMed] [Google Scholar]
  14. Herbert J. M., Augereau J. M., Gleye J., Maffrand J. P. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun. 1990 Nov 15;172(3):993–999. doi: 10.1016/0006-291x(90)91544-3. [DOI] [PubMed] [Google Scholar]
  15. Kew R. R., Grimaldi C. M., Furie M. B., Fleit H. B. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis. J Immunol. 1992 Aug 1;149(3):989–997. [PubMed] [Google Scholar]
  16. Miller D. K., Gillard J. W., Vickers P. J., Sadowski S., Léveillé C., Mancini J. A., Charleson P., Dixon R. A., Ford-Hutchinson A. W., Fortin R. Identification and isolation of a membrane protein necessary for leukotriene production. Nature. 1990 Jan 18;343(6255):278–281. doi: 10.1038/343278a0. [DOI] [PubMed] [Google Scholar]
  17. Murphy P. M. The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol. 1994;12:593–633. doi: 10.1146/annurev.iy.12.040194.003113. [DOI] [PubMed] [Google Scholar]
  18. O'Flaherty J. T., Rossi A. G. 5-hydroxyicosatetraenoate stimulates neutrophils by a stereospecific, G protein-linked mechanism. J Biol Chem. 1993 Jul 15;268(20):14708–14714. [PubMed] [Google Scholar]
  19. Powell W. S., Gravel S., MacLeod R. J., Mills E., Hashefi M. Stimulation of human neutrophils by 5-oxo-6,8,11,14-eicosatetraenoic acid by a mechanism independent of the leukotriene B4 receptor. J Biol Chem. 1993 May 5;268(13):9280–9286. [PubMed] [Google Scholar]
  20. Powell W. S., Gravelle F., Gravel S. Metabolism of 5(S)-hydroxy-6,8,11,14-eicosatetraenoic acid and other 5(S)-hydroxyeicosanoids by a specific dehydrogenase in human polymorphonuclear leukocytes. J Biol Chem. 1992 Sep 25;267(27):19233–19241. [PubMed] [Google Scholar]
  21. Robinson J. M., Karnovsky M. L., Karnovsky M. J. Glycogen accumulation in polymorphonuclear leukocytes, and other intracellular alterations that occur during inflammation. J Cell Biol. 1982 Dec;95(3):933–942. doi: 10.1083/jcb.95.3.933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rossi A. G., O'Flaherty J. T. Bioactions of 5-hydroxyicosatetraenoate and its interaction with platelet-activating factor. Lipids. 1991 Dec;26(12):1184–1188. doi: 10.1007/BF02536528. [DOI] [PubMed] [Google Scholar]
  23. Rossi A. G., Thomas M. J., O'Flaherty J. T. Stereospecific bioactions of 5-hydroxyeicosatetraenoate. FEBS Lett. 1988 Nov 21;240(1-2):163–166. doi: 10.1016/0014-5793(88)80360-0. [DOI] [PubMed] [Google Scholar]
  24. Rüegg U. T., Burgess G. M. Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases. Trends Pharmacol Sci. 1989 Jun;10(6):218–220. doi: 10.1016/0165-6147(89)90263-0. [DOI] [PubMed] [Google Scholar]
  25. Samuelsson B., Dahlén S. E., Lindgren J. A., Rouzer C. A., Serhan C. N. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science. 1987 Sep 4;237(4819):1171–1176. doi: 10.1126/science.2820055. [DOI] [PubMed] [Google Scholar]
  26. Schütze S., Potthoff K., Machleidt T., Berkovic D., Wiegmann K., Krönke M. TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell. 1992 Nov 27;71(5):765–776. doi: 10.1016/0092-8674(92)90553-o. [DOI] [PubMed] [Google Scholar]
  27. Serhan C. N. Eicosanoids in leukocyte function. Curr Opin Hematol. 1994 Jan;1(1):69–77. [PubMed] [Google Scholar]
  28. Serhan C. N. Leukocyte transmigration, chemotaxis, and oxygenated derivatives of arachidonic acid: when is chirality important? Am J Respir Cell Mol Biol. 1995 Mar;12(3):251–253. doi: 10.1165/ajrcmb.12.3.7873189. [DOI] [PubMed] [Google Scholar]
  29. Shukla S. D. Inositol phospholipid turnover in PAF transmembrane signalling. Lipids. 1991 Dec;26(12):1028–1033. doi: 10.1007/BF02536496. [DOI] [PubMed] [Google Scholar]
  30. Stenson W. F., Parker C. W. Metabolism of arachidonic acid in ionophore-stimulated neutrophils. Esterification of a hydroxylated metabolite into phospholipids. J Clin Invest. 1979 Nov;64(5):1457–1465. doi: 10.1172/JCI109604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Stewart A. G., Dubbin P. N., Harris T., Dusting G. J. Platelet-activating factor may act as a second messenger in the release of icosanoids and superoxide anions from leukocytes and endothelial cells. Proc Natl Acad Sci U S A. 1990 Apr;87(8):3215–3219. doi: 10.1073/pnas.87.8.3215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Triggiani M., Oriente A., Seeds M. C., Bass D. A., Marone G., Chilton F. H. Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool. J Exp Med. 1995 Nov 1;182(5):1181–1190. doi: 10.1084/jem.182.5.1181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Verghese M. W., Charles L., Jakoi L., Dillon S. B., Snyderman R. Role of a guanine nucleotide regulatory protein in the activation of phospholipase C by different chemoattractants. J Immunol. 1987 Jun 15;138(12):4374–4380. [PubMed] [Google Scholar]
  34. Weller P. F., Ackerman S. J., Nicholson-Weller A., Dvorak A. M. Cytoplasmic lipid bodies of human neutrophilic leukocytes. Am J Pathol. 1989 Nov;135(5):947–959. [PMC free article] [PubMed] [Google Scholar]
  35. Weller P. F., Monahan-Earley R. A., Dvorak H. F., Dvorak A. M. Cytoplasmic lipid bodies of human eosinophils. Subcellular isolation and analysis of arachidonate incorporation. Am J Pathol. 1991 Jan;138(1):141–148. [PMC free article] [PubMed] [Google Scholar]
  36. Weller P. F., Ryeom S. W., Picard S. T., Ackerman S. J., Dvorak A. M. Cytoplasmic lipid bodies of neutrophils: formation induced by cis-unsaturated fatty acids and mediated by protein kinase C. J Cell Biol. 1991 Apr;113(1):137–146. doi: 10.1083/jcb.113.1.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Yule D. I., Williams J. A. U73122 inhibits Ca2+ oscillations in response to cholecystokinin and carbachol but not to JMV-180 in rat pancreatic acinar cells. J Biol Chem. 1992 Jul 15;267(20):13830–13835. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES